RESUMEN
Occupational dermatology has become a vibrant and interesting specialty, particularly in recent years. This includes more than hand eczema (HE). The increasing prevalence of atopic dermatitis (AD) has led to an increase of atopic hand eczema which can be worsened in certain occupations. New systemic therapies have improved the range of treatments for HE. The current guideline on hand eczema includes a variety of topical and systemic therapies. Nevertheless, in daily occupational dermatological practice, there are still chronic cases, especially vesicular hand eczema. They can often not be assigned to a clear cause, which is often a problem for those who are affected. In addition, co-factors such as chronic infectious comorbidities and psychological factors/illnesses must be considered. We present challenges in occupational dermatology by reporting special cases.
Asunto(s)
Dermatitis Atópica , Dermatitis Profesional , Dermatología , Eccema , Dermatosis de la Mano , Dermatitis Atópica/diagnóstico , Dermatitis Atópica/epidemiología , Dermatitis Profesional/diagnóstico , Dermatitis Profesional/epidemiología , Dermatosis de la Mano/diagnóstico , Dermatosis de la Mano/epidemiología , Dermatosis de la Mano/terapia , HumanosAsunto(s)
Crioterapia , Dermatosis de la Mano/terapia , Queratosis/terapia , Anciano , Femenino , HumanosRESUMEN
Dermatoses of the hands and feet cover a wide range of skin diseases that can occur in children and adolescents and are a frequent question in dermatological practice. Our synopsis of the most important differential diagnoses and their treatment is intended to provide better orientation for daily practice. A precise and detailed history is essential to establish a diagnosis, followed by clinical examination and specific examination methods. Cutaneous infection should always be excluded, as they occur very frequently. Impetigo, punctate keratolysis, blistering distal dactylitis, tinea manuum and pedum, hand-foot-mouth disease, herpes simplex digitalis and verrucae vulgaris as well as scabies are often found in the palmoplantar area and typically affect children and adolescents. In case of allergic contact dermatitis and dyshidrotic eczema, atopic diathesis in the medical history is of importance. However, we must not miss rare causes. Palmoplantar keratoses, for example, can be due to inflammatory dermatoses like pityriasis rubra pilaris (PRP) or may, as well as blistering diseases, result from hereditary disorders. Specialised centers can perform molecular genetic diagnosis and enhance patient care.
Asunto(s)
Dermatosis de la Mano , Queratodermia Palmoplantar , Pitiriasis Rubra Pilaris , Enfermedades Cutáneas Infecciosas , Adolescente , Niño , Dermatosis de la Mano/diagnóstico , Dermatosis de la Mano/terapia , Humanos , TiñaRESUMEN
Chronic hand/foot eczemas are common, but treatment is often challenging, with widespread dissatisfaction over current available options. Detailed history is important, particularly with regard to potential exposure to irritants and allergens. Patch testing should be regarded as a standard investigation. Individual treatment outcomes and targets, including systemic therapy, should be discussed early with patients, restoring function being the primary goal, with clearing the skin a secondary outcome. Each new treatment, where appropriate, should be considered additive or overlapping to any previous therapy. Management extends beyond mere pharmacological or physical treatment, and requires an encompassing approach including removal or avoidance of causative factors, behavioural changes and social support. To date, there is little evidence to guide sequences or combinations of therapies. Moderately symptomatic patients (e.g. DLQI ≥ 10) should be started on a potent/super-potent topical corticosteroid applied once or twice per day for 4 weeks, with tapering to twice weekly application. If response is inadequate, consider phototherapy, and then a 12-week trial of a retinoid (alitretinoin or acitretin). Second line systemic treatments include methotrexate, ciclosporin and azathioprine. For patients presenting with severe symptomatic disease (DLQI ≥ 15), consider predniso(lo)ne 0.5-1.0 mg/kg/day (or ciclosporin 3 - 5 mg/kg/day) for 4-6 weeks with tapering, and then treating as for moderate disease as above. In non-responders, botulinum toxin and/or iontophoresis, if associated with hyperhidrosis, may sometimes help. Some patients only respond to long-term systemic corticosteroids. The data on sequencing of newer agents, such as dupilumab or JAK inhibitors, are immature.
Asunto(s)
Eccema/terapia , Dermatosis del Pie/terapia , Dermatosis de la Mano/terapia , Toxinas Botulínicas/uso terapéutico , Enfermedad Crónica , Fármacos Dermatológicos/uso terapéutico , Eccema/diagnóstico , Dermatosis del Pie/diagnóstico , Glucocorticoides/uso terapéutico , Dermatosis de la Mano/diagnóstico , Humanos , Iontoforesis , Terapia por Láser , Fototerapia , ProbióticosAsunto(s)
COVID-19 , Dermatosis de la Mano/etiología , Desinfección de las Manos , Queratodermia Palmoplantar/etiología , Adulto , COVID-19/prevención & control , Femenino , Dermatosis de la Mano/patología , Dermatosis de la Mano/terapia , Humanos , Queratodermia Palmoplantar/patología , Queratodermia Palmoplantar/terapia , SARS-CoV-2 , Agua/efectos adversosRESUMEN
BACKGROUND: Though topical corticosteroid is a standard treatment for chronic hand eczema (CHE), it can cause many adverse effects. Topical calcipotriol and monochromatic 308-nm excimer light (MEL) are new alternative therapies for several dermatoses, including CHE. OBJECTIVE: This study aims to compare the efficacy of the combination of MEL and topical calcipotriol versus topical calcipotriol alone. METHODS: One hand of the participants was randomly assigned to be irradiated with MEL twice weekly and topical calcipotriol applied twice daily while the other hand was assigned to receive only topical calcipotriol twice daily for 8 weeks. Then, only petrolatum ointment was applied during the 4-week follow-up period. Hand Eczema Severity Index (HECSI) and modified Total Lesion Symptom Score were assessed by a blinded investigator, and a visual analogue scale score of itching symptoms was graded by the participants. RESULTS: In total, 36 hands from 18 subjects completed the protocol. On the combination-treated sides, the mean HECSI score was significantly reduced by 25% (p = 0.015) from the 4th week. Then, it was gradually decreased to 57 and 65% (p < 0.001) at the 8th week and at the follow-up visit, respectively. For the monotherapy-treated sides, the mean HECSI score was reduced to 41% (p = 0.001) and 49% (p < 0.001) at the 8th and 12th week, accordingly. At the end of the treatment period, itching scores were significantly decreased by around 64% (p < 0.001) and 51% (p = 0.002) on the combination-treated and the monotherapy-treated sides. No serious and persistent adverse reactions were found. CONCLUSION: The combined MEL and topical calcipotriol may be considered as an alternatively effective treatment for CHE.
Asunto(s)
Calcitriol/análogos & derivados , Fármacos Dermatológicos/uso terapéutico , Eccema/terapia , Dermatosis de la Mano/terapia , Láseres de Excímeros/uso terapéutico , Terapia por Luz de Baja Intensidad , Administración Tópica , Adulto , Anciano , Calcitriol/uso terapéutico , Enfermedad Crónica , Femenino , Humanos , Masculino , Persona de Mediana Edad , Resultado del TratamientoRESUMEN
BACKGROUND: Assessment of chronic hand eczema (CHE) is complex and warrants standardization. OBJECTIVE: We sought to guide clinicians on the assessment of CHE. METHODS: An electronic questionnaire regarding the diagnosis and assessment of CHE was completed by councilors (n=45) of the International Eczema Council, an international group of clinicians and researchers with expertise in CHE. The survey consisted of 52 statements for consensus. RESULTS: Overall, nine statements (17.3%) had strong, twenty-three (44.2%) moderate, 12 (23.1%) low, and 8 (15.4%) very low levels of agreement. Five statements had considerable disagreement, including the value of conducting a skin biopsy (62.2% disagreement), investigating for possible type 1 reactions (60.0%), conducting a fungal culture (44.4%), finding no history of relevant allergens and/or irritants (31.1%) in most or all cases, and performing patch testing irrespective of lesion location and morphology (28.9%). Agreement was generally highest among respondents from Europe (28.6-77.8% agreement), followed by Asia (7.1%-35.7% agreement), North America (0%-35.5% agreement), and other (0%-13.3% agreement). CONCLUSIONS: There were substantial differences of agreement, suggesting there are many knowledge and/or practice gaps with respect to CHE. Future research is needed to inform evidence-based and/or consensus guidelines for CHE.
Asunto(s)
Actitud del Personal de Salud , Eccema/diagnóstico , Eccema/terapia , Dermatosis de la Mano/diagnóstico , Dermatosis de la Mano/terapia , Pautas de la Práctica en Medicina , Enfermedad Crónica , Competencia Clínica , Protocolos Clínicos , Eccema/etiología , Dermatosis de la Mano/etiología , Humanos , Guías de Práctica Clínica como Asunto , Encuestas y CuestionariosRESUMEN
Coronavirus disease 2019 (COVID-19) pandemic continues to spread globally at a staggering speed. At present, there is no effective treatment or vaccine for COVID-19. Hand disinfection is a cost-effective way to prevent its transmission. According to the Centres for Disease Control and Prevention (CDC) guidelines, we should wash our hands with soap and water for at least 20 seconds. If soap and water are not readily available, alcohol-based hand rubs (ABHRs) with at least 60% alcohol are the alternative. With diligent hand disinfection reinforced during COVID-19, there is an increased prevalence of contact dermatitis. This commentary highlights the fact that contact dermatitis is a readily treatable condition and should not cause any deviation of proper hand hygiene. In irritant contact dermatitis (ICD), the management strategies are selection of less irritating hand hygiene products, frequent use of moisturisers to rebuild the skin barrier, and education on proper hand hygiene practices. In allergic contact dermatitis (ACD), the identification and avoidance of the contact allergen is the key to treatment. However, ACD is less common and only accounts for 20% of the cases. The identified allergens in hand cleansers are predominantly preservative excipients and ACD attributable to ABHR are very uncommon. Alcohol-free hand rubs are widely available on the market but it is not a recommended alternative to ABHRs by the CDC.
Asunto(s)
COVID-19/prevención & control , Dermatitis Alérgica por Contacto/terapia , Dermatitis Irritante/terapia , Emolientes/uso terapéutico , Dermatosis de la Mano/terapia , Desinfección de las Manos/métodos , Higroscópicos/uso terapéutico , 1-Propanol/efectos adversos , 2-Propanol/efectos adversos , Antiinfecciosos Locales/efectos adversos , Dermatitis Alérgica por Contacto/etiología , Dermatitis Irritante/etiología , Dermatitis Profesional/etiología , Dermatitis Profesional/terapia , Detergentes/efectos adversos , Etanol/efectos adversos , Dermatosis de la Mano/etiología , Higiene de las Manos , Desinfectantes para las Manos/efectos adversos , Personal de Salud , HumanosRESUMEN
The aim of this study was to evaluate the skin problems and dermatological life quality of the health care workers (HCWs) due to personal protection equipment (PPE) use, who are at high risk for COVID-19 infection. A questionnaire about HCWs' PPE use, their skin symptoms, and prevention, management methods and Dermatology Life Quality Index (DLQI) was fulfilled. The median age of 440 participants was 33.5 (21.0-65.0) years old. Skin problems were found to be 90.2%, the most common were dryness, itching, cracking, burning, flaking, peeling and lichenification. The presence of skin problems (P < .001) was higher in those who did not use moisturizers. Of all, 22.3% (n = 98) stated that the use of PPE increased the severity of their previously diagnosed skin diseases and allergies (P < .01). Only 28.0% (n = 123) stated that they know the skin symptoms that may develop by using PPE. The proper hand washing rate was higher as education level increased (P < .001). Skin problems were higher in those using mask with metal nose bridge (P: .02 and P: .003, respectively). As the mask using period prolonged, acne was more common (P: .02). DLQI was significantly affected in women (P = .003), and with increased skin problems related to PPE (P < .001). It is important to organize trainings on prevention and management of possible skin symptoms due to PPE use according to guidelines.
Asunto(s)
COVID-19/prevención & control , Dermatitis Profesional/etiología , Dermatosis Facial/etiología , Dermatosis de la Mano/etiología , Desinfección de las Manos , Transmisión de Enfermedad Infecciosa de Paciente a Profesional/prevención & control , Equipo de Protección Personal/efectos adversos , Personal de Hospital , Calidad de Vida , Adulto , Anciano , COVID-19/transmisión , Dermatitis Profesional/diagnóstico , Dermatitis Profesional/terapia , Dermatosis Facial/diagnóstico , Dermatosis Facial/terapia , Femenino , Dermatosis de la Mano/diagnóstico , Dermatosis de la Mano/terapia , Humanos , Masculino , Persona de Mediana Edad , Respiradores N95/efectos adversos , Salud Laboral , Medición de Riesgo , Factores de Riesgo , Adulto JovenAsunto(s)
Infecciones por Coronavirus/prevención & control , Dermatitis Irritante/etiología , Detergentes/efectos adversos , Dermatosis de la Mano/etiología , Desinfección de las Manos/métodos , Pandemias/prevención & control , Neumonía Viral/prevención & control , Betacoronavirus , COVID-19 , Dermatitis Irritante/terapia , Emolientes/uso terapéutico , Dermatosis de la Mano/terapia , Desinfectantes para las Manos , Humanos , Control de Infecciones , Masculino , Persona de Mediana Edad , Educación del Paciente como Asunto , SARS-CoV-2 , Crema para la Piel/uso terapéuticoAsunto(s)
Infecciones por Coronavirus/prevención & control , Eccema/etiología , Dermatosis de la Mano/etiología , Enfermedades Profesionales/epidemiología , Pandemias/prevención & control , Personal de Hospital/estadística & datos numéricos , Neumonía Viral/prevención & control , Administración Tópica , Adulto , COVID-19 , Estudios de Cohortes , Infecciones por Coronavirus/epidemiología , Eccema/epidemiología , Femenino , Dermatosis de la Mano/epidemiología , Dermatosis de la Mano/terapia , Desinfección de las Manos/métodos , Higiene de las Manos , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Enfermedades Profesionales/etiología , Pandemias/estadística & datos numéricos , Neumonía Viral/epidemiología , Estudios Retrospectivos , Medición de Riesgo , Cuidados de la Piel/métodos , Esteroides/uso terapéutico , Resultado del Tratamiento , Estados UnidosAsunto(s)
Dermatitis Profesional/diagnóstico , Dermatología , Personal de Salud , Salud Laboral , Equipo de Protección Personal/efectos adversos , Telemedicina/organización & administración , Betacoronavirus , COVID-19 , Infecciones por Coronavirus/prevención & control , Infecciones por Coronavirus/transmisión , Dermatitis Profesional/etiología , Dermatitis Profesional/terapia , Dermatosis Facial/diagnóstico , Dermatosis Facial/etiología , Dermatosis Facial/terapia , Dermatosis de la Mano/diagnóstico , Dermatosis de la Mano/etiología , Dermatosis de la Mano/terapia , Humanos , Transmisión de Enfermedad Infecciosa de Paciente a Profesional/prevención & control , Enfermería del Trabajo , Pandemias/prevención & control , Neumonía Viral/prevención & control , Neumonía Viral/transmisión , SARS-CoV-2 , Telemedicina/métodos , GalesRESUMEN
Environmental history exposed the diagnosis.
Asunto(s)
Vesícula/terapia , Cianosis/terapia , Edema/terapia , Congelación de Extremidades/diagnóstico , Congelación de Extremidades/terapia , Dermatosis de la Mano/diagnóstico , Dermatosis de la Mano/terapia , Adulto , Vesícula/diagnóstico , Cianosis/diagnóstico , Edema/diagnóstico , Humanos , Masculino , Recalentamiento/métodos , Resultado del TratamientoAsunto(s)
Infecciones por Coronavirus/epidemiología , Dermatitis Alérgica por Contacto/prevención & control , Dermatitis Profesional/prevención & control , Dermatología , Dermatosis de la Mano/prevención & control , Salud Laboral , Equipo de Protección Personal/efectos adversos , Neumonía Viral/epidemiología , Betacoronavirus , COVID-19 , Infecciones por Coronavirus/prevención & control , Dermatitis Alérgica por Contacto/etiología , Dermatitis Alérgica por Contacto/terapia , Dermatitis Profesional/etiología , Dermatitis Profesional/terapia , Dermatosis de la Mano/etiología , Dermatosis de la Mano/terapia , Desinfección de las Manos/métodos , Personal de Salud , Humanos , Pandemias/prevención & control , Neumonía Viral/prevención & control , SARS-CoV-2 , Cuidados de la Piel/métodosRESUMEN
While many hand infections are superficial, diligent evaluation, diagnosis, and treatment of these infections are central for preventing disability and morbidity. Maintaining a wide differential diagnosis is important as some hand infections may mimic others. In geographic areas with more than a 10% to 15% prevalence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) hand infections, empiric antibiotics should adequately cover MRSA. Once culture results are available, antibiotic regimens should be narrowed to reduce the development of resistant pathogens.